Boston, MANCT06283251Now EnrollingIRB Ready

Pediatric Cancer Clinical Trial in Boston, MA

Access cutting-edge pediatric cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Dana-Farber Cancer Institute

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access pediatric cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pediatric cancer treatment provided free

Apply for This Boston Location

Check if you qualify for this pediatric cancer clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Pediatric Cancer Study in Boston

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Sponsor: Dana-Farber Cancer Institute

Who Can Participate

Inclusion Criteria

Cohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy
Child diagnosed with de novo cancer
Child has established care at a study site and initiated cancer directed therapy in the prior 2-months
Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan
Child is \<18 years at time of enrollment
Parent/guardian screened positive for self-reported low-income (\<200% FPL)
Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI
Provider approval for permission to approach Cohort 2: Poverty-exposed children with cancer undergoing HSCT
Child undergoing allogeneic HSCT for treatment of cancer
Child has established care at a study site and is between 30 days prior to start of planned conditioning through day +7 of HSCT at time of enrollment
Child planned to receive follow-up care after discharge for HSCT at study site
Child is \<18 years at the time of enrollment
Parent/guardian screen positive for self-reported low-income (\<200% FPL)
Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI
Provider approval for permission to approach

Exclusion Criteria

Cohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy
Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy
Foreign national family receiving care as an Embassy-pay patient
Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies
Child or household member receiving SSI Cohort 2: Poverty-exposed children with cancer undergoing HSCT
Planned transfer of child to a non-DFCI, non-Columbia, or non UCSF facility for cancer-directed therapy
Foreign national family receiving care as an Embassy-pay patient
Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies
Child previously received RISE intervention
Child or household member receiving SSI

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06283251) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pediatric Cancer Treatment Options in Boston, MA

If you're searching for pediatric cancer treatment options in Boston, MA, this clinical trial (NCT06283251) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pediatric cancer clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsPediatric Cancer TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA